Access to Risdiplam in Scotland: Your Views

02 September 2021

Please let us know your views so that we can pass them on to the Scottish Medicines Consortium (SMC).

As you have may have heard, the Scottish Medicines Consortium (SMC) has now started its review of whether to recommend risdiplam for funding by the NHS in Scotland. Patient groups have been invited to make submissions by 4th October 2021. SMA UK and MDUK are writing their submission jointly, as we’ve done for other treatments in both Scotland and England.

We want our submission to reflect the views of people in Scotland who are affected by SMA, including those who are bereaved by SMA, so we’re putting out this short survey with a closing date of Thursday 16th September

We will also draw on the work we have done already advocating for access to risdiplam in England:

Take the survey here

We look forward to hearing from you. Thank you.